nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP2C9—brain cancer	0.516	1	CbGaD
Sertraline—CYP2D6—Lomustine—brain cancer	0.0556	0.207	CbGbCtD
Sertraline—CYP1A2—Carmustine—brain cancer	0.055	0.205	CbGbCtD
Sertraline—CYP2D6—Hydroxyurea—brain cancer	0.0421	0.157	CbGbCtD
Sertraline—CYP3A4—Temozolomide—brain cancer	0.0416	0.155	CbGbCtD
Sertraline—CYP3A4—Lomustine—brain cancer	0.0354	0.132	CbGbCtD
Sertraline—CYP1A2—Etoposide—brain cancer	0.0163	0.0607	CbGbCtD
Sertraline—ABCB1—Etoposide—brain cancer	0.0143	0.0531	CbGbCtD
Sertraline—CYP3A4—Etoposide—brain cancer	0.00854	0.0318	CbGbCtD
Sertraline—SLC6A3—telencephalic ventricle—brain cancer	0.00294	0.0636	CbGeAlD
Sertraline—SLC6A3—ganglion—brain cancer	0.00183	0.0396	CbGeAlD
Sertraline—SLC6A4—ganglion—brain cancer	0.00168	0.0363	CbGeAlD
Sertraline—MAOB—ganglion—brain cancer	0.0016	0.0345	CbGeAlD
Sertraline—SLC6A2—ganglion—brain cancer	0.00148	0.0319	CbGeAlD
Sertraline—SLC6A3—hindbrain—brain cancer	0.00139	0.03	CbGeAlD
Sertraline—MAOA—ganglion—brain cancer	0.00136	0.0294	CbGeAlD
Sertraline—SLC6A4—hindbrain—brain cancer	0.00127	0.0275	CbGeAlD
Sertraline—MAOB—hindbrain—brain cancer	0.00121	0.0261	CbGeAlD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—OTX2—brain cancer	0.00116	0.0526	CbGpPWpGaD
Sertraline—MAOA—hindbrain—brain cancer	0.00103	0.0223	CbGeAlD
Sertraline—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.000893	0.0405	CbGpPWpGaD
Sertraline—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000871	0.0395	CbGpPWpGaD
Sertraline—SLC6A3—brainstem—brain cancer	0.000796	0.0172	CbGeAlD
Sertraline—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000793	0.0359	CbGpPWpGaD
Sertraline—SLC6A4—Synaptic Vesicle Pathway—SYP—brain cancer	0.000755	0.0342	CbGpPWpGaD
Sertraline—SLC6A4—brainstem—brain cancer	0.00073	0.0158	CbGeAlD
Sertraline—SLC6A3—telencephalon—brain cancer	0.000707	0.0153	CbGeAlD
Sertraline—MAOB—brainstem—brain cancer	0.000694	0.015	CbGeAlD
Sertraline—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000679	0.0308	CbGpPWpGaD
Sertraline—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000675	0.0306	CbGpPWpGaD
Sertraline—SLC6A4—telencephalon—brain cancer	0.000648	0.014	CbGeAlD
Sertraline—SIGMAR1—telencephalon—brain cancer	0.000643	0.0139	CbGeAlD
Sertraline—SLC6A2—brainstem—brain cancer	0.000643	0.0139	CbGeAlD
Sertraline—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000621	0.0282	CbGpPWpGaD
Sertraline—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000618	0.028	CbGpPWpGaD
Sertraline—MAOB—telencephalon—brain cancer	0.000616	0.0133	CbGeAlD
Sertraline—CYP2D6—hindbrain—brain cancer	0.000614	0.0133	CbGeAlD
Sertraline—MAOA—brainstem—brain cancer	0.000592	0.0128	CbGeAlD
Sertraline—SLC6A2—telencephalon—brain cancer	0.00057	0.0123	CbGeAlD
Sertraline—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000554	0.0251	CbGpPWpGaD
Sertraline—MAOA—telencephalon—brain cancer	0.000525	0.0113	CbGeAlD
Sertraline—SIGMAR1—pituitary gland—brain cancer	0.000524	0.0113	CbGeAlD
Sertraline—SLC6A3—midbrain—brain cancer	0.000508	0.011	CbGeAlD
Sertraline—SIGMAR1—medulla oblongata—brain cancer	0.000505	0.0109	CbGeAlD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—GLI2—brain cancer	0.000505	0.0229	CbGpPWpGaD
Sertraline—MAOB—pituitary gland—brain cancer	0.000501	0.0108	CbGeAlD
Sertraline—SLC6A3—spinal cord—brain cancer	0.000495	0.0107	CbGeAlD
Sertraline—MAOB—medulla oblongata—brain cancer	0.000484	0.0104	CbGeAlD
Sertraline—SLC6A2—gonad—brain cancer	0.000476	0.0103	CbGeAlD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—GLI1—brain cancer	0.000475	0.0215	CbGpPWpGaD
Sertraline—MAOB—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000474	0.0215	CbGpPWpGaD
Sertraline—SLC6A4—midbrain—brain cancer	0.000465	0.01	CbGeAlD
Sertraline—ABCB1—blood vessel—brain cancer	0.000463	0.01	CbGeAlD
Sertraline—SIGMAR1—midbrain—brain cancer	0.000462	0.00998	CbGeAlD
Sertraline—SLC6A4—spinal cord—brain cancer	0.000454	0.0098	CbGeAlD
Sertraline—SIGMAR1—spinal cord—brain cancer	0.000451	0.00973	CbGeAlD
Sertraline—SLC6A2—medulla oblongata—brain cancer	0.000448	0.00967	CbGeAlD
Sertraline—MAOB—midbrain—brain cancer	0.000442	0.00955	CbGeAlD
Sertraline—SLC6A3—head—brain cancer	0.00044	0.0095	CbGeAlD
Sertraline—MAOB—spinal cord—brain cancer	0.000431	0.00932	CbGeAlD
Sertraline—MAOA—pituitary gland—brain cancer	0.000428	0.00924	CbGeAlD
Sertraline—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.000418	0.019	CbGpPWpGaD
Sertraline—MAOA—medulla oblongata—brain cancer	0.000413	0.00891	CbGeAlD
Sertraline—SLC6A4—endocrine gland—brain cancer	0.000409	0.00882	CbGeAlD
Sertraline—SLC6A4—head—brain cancer	0.000403	0.00871	CbGeAlD
Sertraline—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000402	0.0183	CbGpPWpGaD
Sertraline—SLC6A3—central nervous system—brain cancer	0.000402	0.00868	CbGeAlD
Sertraline—SLC6A3—cerebellum—brain cancer	0.000393	0.00848	CbGeAlD
Sertraline—MAOB—endocrine gland—brain cancer	0.000388	0.00839	CbGeAlD
Sertraline—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000385	0.0175	CbGpPWpGaD
Sertraline—MAOB—head—brain cancer	0.000383	0.00828	CbGeAlD
Sertraline—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00038	0.0172	CbGpPWpGaD
Sertraline—MAOA—midbrain—brain cancer	0.000377	0.00815	CbGeAlD
Sertraline—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00037	0.0168	CbGpPWpGaD
Sertraline—SLC6A4—central nervous system—brain cancer	0.000368	0.00795	CbGeAlD
Sertraline—MAOA—spinal cord—brain cancer	0.000368	0.00795	CbGeAlD
Sertraline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000362	0.0164	CbGpPWpGaD
Sertraline—SLC6A2—endocrine gland—brain cancer	0.00036	0.00777	CbGeAlD
Sertraline—SIGMAR1—cerebellum—brain cancer	0.000357	0.00772	CbGeAlD
Sertraline—SLC6A2—head—brain cancer	0.000355	0.00767	CbGeAlD
Sertraline—CYP2D6—brainstem—brain cancer	0.000352	0.0076	CbGeAlD
Sertraline—CYP2B6—gonad—brain cancer	0.000351	0.00757	CbGeAlD
Sertraline—MAOB—central nervous system—brain cancer	0.00035	0.00756	CbGeAlD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—SHH—brain cancer	0.000343	0.0156	CbGpPWpGaD
Sertraline—MAOB—cerebellum—brain cancer	0.000342	0.00739	CbGeAlD
Sertraline—CYP2C19—endocrine gland—brain cancer	0.000339	0.00731	CbGeAlD
Sertraline—MAOA—endocrine gland—brain cancer	0.000331	0.00716	CbGeAlD
Sertraline—MAOA—head—brain cancer	0.000327	0.00706	CbGeAlD
Sertraline—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000326	0.0148	CbGpPWpGaD
Sertraline—SLC6A2—central nervous system—brain cancer	0.000324	0.007	CbGeAlD
Sertraline—SLC6A3—brain—brain cancer	0.000319	0.00689	CbGeAlD
Sertraline—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000314	0.0142	CbGpPWpGaD
Sertraline—CYP2D6—telencephalon—brain cancer	0.000312	0.00674	CbGeAlD
Sertraline—MAOA—central nervous system—brain cancer	0.000299	0.00645	CbGeAlD
Sertraline—MAOA—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000298	0.0135	CbGpPWpGaD
Sertraline—SLC6A4—brain—brain cancer	0.000292	0.00631	CbGeAlD
Sertraline—MAOA—cerebellum—brain cancer	0.000292	0.0063	CbGeAlD
Sertraline—SIGMAR1—brain—brain cancer	0.00029	0.00627	CbGeAlD
Sertraline—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000287	0.013	CbGpPWpGaD
Sertraline—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00028	0.0127	CbGpPWpGaD
Sertraline—MAOB—brain—brain cancer	0.000278	0.006	CbGeAlD
Sertraline—CYP1A2—endocrine gland—brain cancer	0.000276	0.00597	CbGeAlD
Sertraline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000267	0.0121	CbGpPWpGaD
Sertraline—CYP2B6—endocrine gland—brain cancer	0.000265	0.00572	CbGeAlD
Sertraline—CYP2C9—endocrine gland—brain cancer	0.000262	0.00567	CbGeAlD
Sertraline—CYP2B6—head—brain cancer	0.000262	0.00565	CbGeAlD
Sertraline—SLC6A2—brain—brain cancer	0.000257	0.00556	CbGeAlD
Sertraline—MAOB—Biological oxidations—CYP2C9—brain cancer	0.000252	0.0114	CbGpPWpGaD
Sertraline—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000252	0.0114	CbGpPWpGaD
Sertraline—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000242	0.011	CbGpPWpGaD
Sertraline—CYP2B6—central nervous system—brain cancer	0.000239	0.00516	CbGeAlD
Sertraline—MAOA—brain—brain cancer	0.000237	0.00512	CbGeAlD
Sertraline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00023	0.0104	CbGpPWpGaD
Sertraline—MAOA—Oxidative Stress—SOD2—brain cancer	0.000229	0.0104	CbGpPWpGaD
Sertraline—Haemorrhage—Carmustine—brain cancer	0.000229	0.00155	CcSEcCtD
Sertraline—Ill-defined disorder—Hydroxyurea—brain cancer	0.000228	0.00155	CcSEcCtD
Sertraline—Anaemia—Hydroxyurea—brain cancer	0.000227	0.00155	CcSEcCtD
Sertraline—Hallucination—Carmustine—brain cancer	0.000227	0.00154	CcSEcCtD
Sertraline—Hypoaesthesia—Carmustine—brain cancer	0.000227	0.00154	CcSEcCtD
Sertraline—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000227	0.0103	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—HES5—brain cancer	0.000227	0.0103	CbGpPWpGaD
Sertraline—Decreased appetite—Procarbazine—brain cancer	0.000226	0.00153	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Etoposide—brain cancer	0.000225	0.00153	CcSEcCtD
Sertraline—Oedema peripheral—Carmustine—brain cancer	0.000225	0.00153	CcSEcCtD
Sertraline—ABCB1—telencephalon—brain cancer	0.000225	0.00485	CbGeAlD
Sertraline—Connective tissue disorder—Carmustine—brain cancer	0.000225	0.00153	CcSEcCtD
Sertraline—Fatigue—Procarbazine—brain cancer	0.000224	0.00152	CcSEcCtD
Sertraline—Haemoglobin—Temozolomide—brain cancer	0.000222	0.00151	CcSEcCtD
Sertraline—Malaise—Hydroxyurea—brain cancer	0.000222	0.00151	CcSEcCtD
Sertraline—Constipation—Procarbazine—brain cancer	0.000222	0.00151	CcSEcCtD
Sertraline—Pain—Procarbazine—brain cancer	0.000222	0.00151	CcSEcCtD
Sertraline—Hepatitis—Temozolomide—brain cancer	0.000221	0.0015	CcSEcCtD
Sertraline—Haemorrhage—Temozolomide—brain cancer	0.000221	0.0015	CcSEcCtD
Sertraline—Dysphagia—Etoposide—brain cancer	0.000221	0.0015	CcSEcCtD
Sertraline—Leukopenia—Hydroxyurea—brain cancer	0.00022	0.0015	CcSEcCtD
Sertraline—Visual impairment—Carmustine—brain cancer	0.00022	0.0015	CcSEcCtD
Sertraline—Hallucination—Temozolomide—brain cancer	0.00022	0.00149	CcSEcCtD
Sertraline—Hypoaesthesia—Temozolomide—brain cancer	0.00022	0.00149	CcSEcCtD
Sertraline—Pharyngitis—Temozolomide—brain cancer	0.000219	0.00149	CcSEcCtD
Sertraline—Urinary tract disorder—Temozolomide—brain cancer	0.000218	0.00148	CcSEcCtD
Sertraline—Oedema peripheral—Temozolomide—brain cancer	0.000218	0.00148	CcSEcCtD
Sertraline—Bronchospasm—Etoposide—brain cancer	0.000217	0.00148	CcSEcCtD
Sertraline—Connective tissue disorder—Temozolomide—brain cancer	0.000217	0.00147	CcSEcCtD
Sertraline—Urethral disorder—Temozolomide—brain cancer	0.000216	0.00147	CcSEcCtD
Sertraline—Sweating increased—Etoposide—brain cancer	0.000215	0.00146	CcSEcCtD
Sertraline—Feeling abnormal—Procarbazine—brain cancer	0.000214	0.00145	CcSEcCtD
Sertraline—Eye disorder—Carmustine—brain cancer	0.000214	0.00145	CcSEcCtD
Sertraline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000213	0.00967	CbGpPWpGaD
Sertraline—Convulsion—Hydroxyurea—brain cancer	0.000213	0.00145	CcSEcCtD
Sertraline—Visual impairment—Temozolomide—brain cancer	0.000213	0.00145	CcSEcCtD
Sertraline—Gastrointestinal pain—Procarbazine—brain cancer	0.000212	0.00144	CcSEcCtD
Sertraline—Flushing—Carmustine—brain cancer	0.000212	0.00144	CcSEcCtD
Sertraline—Pancytopenia—Etoposide—brain cancer	0.00021	0.00142	CcSEcCtD
Sertraline—Erythema multiforme—Temozolomide—brain cancer	0.000209	0.00142	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000208	0.00141	CcSEcCtD
Sertraline—Discomfort—Hydroxyurea—brain cancer	0.000207	0.00141	CcSEcCtD
Sertraline—Eye disorder—Temozolomide—brain cancer	0.000206	0.0014	CcSEcCtD
Sertraline—Urticaria—Procarbazine—brain cancer	0.000206	0.0014	CcSEcCtD
Sertraline—Tinnitus—Temozolomide—brain cancer	0.000206	0.0014	CcSEcCtD
Sertraline—Abdominal pain—Procarbazine—brain cancer	0.000205	0.00139	CcSEcCtD
Sertraline—Body temperature increased—Procarbazine—brain cancer	0.000205	0.00139	CcSEcCtD
Sertraline—Cardiac disorder—Temozolomide—brain cancer	0.000205	0.00139	CcSEcCtD
Sertraline—Flushing—Temozolomide—brain cancer	0.000205	0.00139	CcSEcCtD
Sertraline—Arrhythmia—Carmustine—brain cancer	0.000204	0.00139	CcSEcCtD
Sertraline—Alopecia—Carmustine—brain cancer	0.000202	0.00137	CcSEcCtD
Sertraline—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000201	0.00912	CbGpPWpGaD
Sertraline—Oedema—Hydroxyurea—brain cancer	0.000201	0.00136	CcSEcCtD
Sertraline—Angiopathy—Temozolomide—brain cancer	0.0002	0.00136	CcSEcCtD
Sertraline—Mental disorder—Carmustine—brain cancer	0.0002	0.00136	CcSEcCtD
Sertraline—CYP3A4—endocrine gland—brain cancer	0.0002	0.00432	CbGeAlD
Sertraline—Immune system disorder—Temozolomide—brain cancer	0.000199	0.00136	CcSEcCtD
Sertraline—Mediastinal disorder—Temozolomide—brain cancer	0.000199	0.00135	CcSEcCtD
Sertraline—Erythema—Carmustine—brain cancer	0.000199	0.00135	CcSEcCtD
Sertraline—Malnutrition—Carmustine—brain cancer	0.000199	0.00135	CcSEcCtD
Sertraline—Chills—Temozolomide—brain cancer	0.000198	0.00135	CcSEcCtD
Sertraline—Nervous system disorder—Hydroxyurea—brain cancer	0.000197	0.00134	CcSEcCtD
Sertraline—CYP2D6—endocrine gland—brain cancer	0.000197	0.00425	CbGeAlD
Sertraline—Thrombocytopenia—Hydroxyurea—brain cancer	0.000197	0.00134	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000195	0.00133	CcSEcCtD
Sertraline—Alopecia—Temozolomide—brain cancer	0.000195	0.00133	CcSEcCtD
Sertraline—Skin disorder—Hydroxyurea—brain cancer	0.000195	0.00133	CcSEcCtD
Sertraline—CYP2D6—head—brain cancer	0.000194	0.0042	CbGeAlD
Sertraline—Acute coronary syndrome—Etoposide—brain cancer	0.000194	0.00132	CcSEcCtD
Sertraline—Mental disorder—Temozolomide—brain cancer	0.000193	0.00131	CcSEcCtD
Sertraline—Myocardial infarction—Etoposide—brain cancer	0.000193	0.00131	CcSEcCtD
Sertraline—Neuropathy peripheral—Etoposide—brain cancer	0.000193	0.00131	CcSEcCtD
Sertraline—Back pain—Carmustine—brain cancer	0.000192	0.00131	CcSEcCtD
Sertraline—Malnutrition—Temozolomide—brain cancer	0.000192	0.00131	CcSEcCtD
Sertraline—Erythema—Temozolomide—brain cancer	0.000192	0.00131	CcSEcCtD
Sertraline—Jaundice—Etoposide—brain cancer	0.000192	0.0013	CcSEcCtD
Sertraline—Stomatitis—Etoposide—brain cancer	0.000192	0.0013	CcSEcCtD
Sertraline—Anorexia—Hydroxyurea—brain cancer	0.000191	0.0013	CcSEcCtD
Sertraline—Hypersensitivity—Procarbazine—brain cancer	0.000191	0.0013	CcSEcCtD
Sertraline—SLC6A4—Circadian rythm related genes—NTRK3—brain cancer	0.000191	0.00866	CbGpPWpGaD
Sertraline—CYP2B6—brain—brain cancer	0.00019	0.00409	CbGeAlD
Sertraline—Dysgeusia—Temozolomide—brain cancer	0.000188	0.00128	CcSEcCtD
Sertraline—ABCB1—gonad—brain cancer	0.000187	0.00405	CbGeAlD
Sertraline—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000186	0.00845	CbGpPWpGaD
Sertraline—Tremor—Carmustine—brain cancer	0.000186	0.00127	CcSEcCtD
Sertraline—Asthenia—Procarbazine—brain cancer	0.000186	0.00126	CcSEcCtD
Sertraline—Hepatobiliary disease—Etoposide—brain cancer	0.000186	0.00126	CcSEcCtD
Sertraline—Back pain—Temozolomide—brain cancer	0.000186	0.00126	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—HES5—brain cancer	0.000186	0.00842	CbGpPWpGaD
Sertraline—Anaemia—Carmustine—brain cancer	0.000184	0.00125	CcSEcCtD
Sertraline—Agranulocytosis—Etoposide—brain cancer	0.000184	0.00125	CcSEcCtD
Sertraline—Pruritus—Procarbazine—brain cancer	0.000184	0.00125	CcSEcCtD
Sertraline—ABCB1—pituitary gland—brain cancer	0.000183	0.00395	CbGeAlD
Sertraline—Agitation—Carmustine—brain cancer	0.000183	0.00124	CcSEcCtD
Sertraline—SLC6A3—Parkinsons Disease Pathway—CCNE1—brain cancer	0.000181	0.0082	CbGpPWpGaD
Sertraline—CYP3A4—central nervous system—brain cancer	0.00018	0.00389	CbGeAlD
Sertraline—Tremor—Temozolomide—brain cancer	0.00018	0.00122	CcSEcCtD
Sertraline—Dyspnoea—Hydroxyurea—brain cancer	0.000179	0.00122	CcSEcCtD
Sertraline—Somnolence—Hydroxyurea—brain cancer	0.000179	0.00121	CcSEcCtD
Sertraline—Ill-defined disorder—Temozolomide—brain cancer	0.000178	0.00121	CcSEcCtD
Sertraline—Leukopenia—Carmustine—brain cancer	0.000178	0.00121	CcSEcCtD
Sertraline—Anaemia—Temozolomide—brain cancer	0.000178	0.00121	CcSEcCtD
Sertraline—Diarrhoea—Procarbazine—brain cancer	0.000178	0.00121	CcSEcCtD
Sertraline—CYP2D6—central nervous system—brain cancer	0.000177	0.00383	CbGeAlD
Sertraline—Dyspepsia—Hydroxyurea—brain cancer	0.000177	0.0012	CcSEcCtD
Sertraline—Agitation—Temozolomide—brain cancer	0.000177	0.0012	CcSEcCtD
Sertraline—ABCB1—medulla oblongata—brain cancer	0.000176	0.00381	CbGeAlD
Sertraline—Hypoaesthesia—Etoposide—brain cancer	0.000176	0.00119	CcSEcCtD
Sertraline—Angioedema—Temozolomide—brain cancer	0.000176	0.00119	CcSEcCtD
Sertraline—Decreased appetite—Hydroxyurea—brain cancer	0.000175	0.00119	CcSEcCtD
Sertraline—Urinary tract disorder—Etoposide—brain cancer	0.000175	0.00119	CcSEcCtD
Sertraline—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000174	0.00788	CbGpPWpGaD
Sertraline—CYP2D6—cerebellum—brain cancer	0.000173	0.00375	CbGeAlD
Sertraline—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000173	0.00118	CcSEcCtD
Sertraline—Malaise—Temozolomide—brain cancer	0.000173	0.00118	CcSEcCtD
Sertraline—Urethral disorder—Etoposide—brain cancer	0.000173	0.00118	CcSEcCtD
Sertraline—Fatigue—Hydroxyurea—brain cancer	0.000173	0.00118	CcSEcCtD
Sertraline—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000173	0.00784	CbGpPWpGaD
Sertraline—Vertigo—Temozolomide—brain cancer	0.000173	0.00117	CcSEcCtD
Sertraline—Convulsion—Carmustine—brain cancer	0.000172	0.00117	CcSEcCtD
Sertraline—Leukopenia—Temozolomide—brain cancer	0.000172	0.00117	CcSEcCtD
Sertraline—Hypertension—Carmustine—brain cancer	0.000172	0.00117	CcSEcCtD
Sertraline—Constipation—Hydroxyurea—brain cancer	0.000172	0.00117	CcSEcCtD
Sertraline—Pain—Hydroxyurea—brain cancer	0.000172	0.00117	CcSEcCtD
Sertraline—Dizziness—Procarbazine—brain cancer	0.000172	0.00117	CcSEcCtD
Sertraline—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000171	0.00778	CbGpPWpGaD
Sertraline—Palpitations—Temozolomide—brain cancer	0.00017	0.00115	CcSEcCtD
Sertraline—Chest pain—Carmustine—brain cancer	0.000169	0.00115	CcSEcCtD
Sertraline—Myalgia—Carmustine—brain cancer	0.000169	0.00115	CcSEcCtD
Sertraline—Anxiety—Carmustine—brain cancer	0.000169	0.00115	CcSEcCtD
Sertraline—Cough—Temozolomide—brain cancer	0.000168	0.00114	CcSEcCtD
Sertraline—Erythema multiforme—Etoposide—brain cancer	0.000167	0.00114	CcSEcCtD
Sertraline—Convulsion—Temozolomide—brain cancer	0.000167	0.00113	CcSEcCtD
Sertraline—Hypertension—Temozolomide—brain cancer	0.000166	0.00113	CcSEcCtD
Sertraline—Feeling abnormal—Hydroxyurea—brain cancer	0.000165	0.00112	CcSEcCtD
Sertraline—Eye disorder—Etoposide—brain cancer	0.000165	0.00112	CcSEcCtD
Sertraline—Vomiting—Procarbazine—brain cancer	0.000165	0.00112	CcSEcCtD
Sertraline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000165	0.00746	CbGpPWpGaD
Sertraline—Flushing—Etoposide—brain cancer	0.000164	0.00111	CcSEcCtD
Sertraline—Cardiac disorder—Etoposide—brain cancer	0.000164	0.00111	CcSEcCtD
Sertraline—Confusional state—Carmustine—brain cancer	0.000164	0.00111	CcSEcCtD
Sertraline—Arthralgia—Temozolomide—brain cancer	0.000164	0.00111	CcSEcCtD
Sertraline—Myalgia—Temozolomide—brain cancer	0.000164	0.00111	CcSEcCtD
Sertraline—Rash—Procarbazine—brain cancer	0.000164	0.00111	CcSEcCtD
Sertraline—Dermatitis—Procarbazine—brain cancer	0.000163	0.00111	CcSEcCtD
Sertraline—Anxiety—Temozolomide—brain cancer	0.000163	0.00111	CcSEcCtD
Sertraline—Headache—Procarbazine—brain cancer	0.000163	0.0011	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000163	0.0011	CcSEcCtD
Sertraline—Oedema—Carmustine—brain cancer	0.000162	0.0011	CcSEcCtD
Sertraline—Discomfort—Temozolomide—brain cancer	0.000162	0.0011	CcSEcCtD
Sertraline—ABCB1—midbrain—brain cancer	0.000161	0.00348	CbGeAlD
Sertraline—Angiopathy—Etoposide—brain cancer	0.00016	0.00109	CcSEcCtD
Sertraline—Dry mouth—Temozolomide—brain cancer	0.00016	0.00109	CcSEcCtD
Sertraline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00016	0.00725	CbGpPWpGaD
Sertraline—Immune system disorder—Etoposide—brain cancer	0.00016	0.00108	CcSEcCtD
Sertraline—Mediastinal disorder—Etoposide—brain cancer	0.000159	0.00108	CcSEcCtD
Sertraline—Thrombocytopenia—Carmustine—brain cancer	0.000159	0.00108	CcSEcCtD
Sertraline—Body temperature increased—Hydroxyurea—brain cancer	0.000159	0.00108	CcSEcCtD
Sertraline—Chills—Etoposide—brain cancer	0.000159	0.00108	CcSEcCtD
Sertraline—Tachycardia—Carmustine—brain cancer	0.000158	0.00108	CcSEcCtD
Sertraline—Confusional state—Temozolomide—brain cancer	0.000158	0.00107	CcSEcCtD
Sertraline—MAOA—Biological oxidations—CYP2C9—brain cancer	0.000158	0.00717	CbGpPWpGaD
Sertraline—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000158	0.00715	CbGpPWpGaD
Sertraline—ABCB1—spinal cord—brain cancer	0.000157	0.0034	CbGeAlD
Sertraline—Anaphylactic shock—Temozolomide—brain cancer	0.000157	0.00107	CcSEcCtD
Sertraline—Oedema—Temozolomide—brain cancer	0.000157	0.00107	CcSEcCtD
Sertraline—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000157	0.0071	CbGpPWpGaD
Sertraline—Alopecia—Etoposide—brain cancer	0.000156	0.00106	CcSEcCtD
Sertraline—Anorexia—Carmustine—brain cancer	0.000155	0.00105	CcSEcCtD
Sertraline—Nausea—Procarbazine—brain cancer	0.000154	0.00105	CcSEcCtD
Sertraline—Nervous system disorder—Temozolomide—brain cancer	0.000154	0.00105	CcSEcCtD
Sertraline—Thrombocytopenia—Temozolomide—brain cancer	0.000154	0.00104	CcSEcCtD
Sertraline—Skin disorder—Temozolomide—brain cancer	0.000152	0.00104	CcSEcCtD
Sertraline—Hypotension—Carmustine—brain cancer	0.000152	0.00103	CcSEcCtD
Sertraline—Hyperhidrosis—Temozolomide—brain cancer	0.000152	0.00103	CcSEcCtD
Sertraline—Dysgeusia—Etoposide—brain cancer	0.000151	0.00102	CcSEcCtD
Sertraline—Anorexia—Temozolomide—brain cancer	0.00015	0.00102	CcSEcCtD
Sertraline—Back pain—Etoposide—brain cancer	0.000149	0.00101	CcSEcCtD
Sertraline—Hypersensitivity—Hydroxyurea—brain cancer	0.000148	0.00101	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Carmustine—brain cancer	0.000148	0.001	CcSEcCtD
Sertraline—Muscle spasms—Etoposide—brain cancer	0.000148	0.001	CcSEcCtD
Sertraline—Insomnia—Carmustine—brain cancer	0.000147	0.000998	CcSEcCtD
Sertraline—Paraesthesia—Carmustine—brain cancer	0.000146	0.00099	CcSEcCtD
Sertraline—Dyspnoea—Carmustine—brain cancer	0.000145	0.000983	CcSEcCtD
Sertraline—Somnolence—Carmustine—brain cancer	0.000144	0.000981	CcSEcCtD
Sertraline—Asthenia—Hydroxyurea—brain cancer	0.000144	0.000979	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000143	0.000971	CcSEcCtD
Sertraline—Ill-defined disorder—Etoposide—brain cancer	0.000143	0.00097	CcSEcCtD
Sertraline—Anaemia—Etoposide—brain cancer	0.000142	0.000966	CcSEcCtD
Sertraline—Insomnia—Temozolomide—brain cancer	0.000142	0.000964	CcSEcCtD
Sertraline—ABCB1—endocrine gland—brain cancer	0.000142	0.00306	CbGeAlD
Sertraline—Decreased appetite—Carmustine—brain cancer	0.000141	0.000959	CcSEcCtD
Sertraline—CYP2D6—brain—brain cancer	0.000141	0.00304	CbGeAlD
Sertraline—Paraesthesia—Temozolomide—brain cancer	0.000141	0.000957	CcSEcCtD
Sertraline—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000141	0.00639	CbGpPWpGaD
Sertraline—Gastrointestinal disorder—Carmustine—brain cancer	0.00014	0.000952	CcSEcCtD
Sertraline—Dyspnoea—Temozolomide—brain cancer	0.00014	0.00095	CcSEcCtD
Sertraline—ABCB1—head—brain cancer	0.00014	0.00302	CbGeAlD
Sertraline—Somnolence—Temozolomide—brain cancer	0.000139	0.000948	CcSEcCtD
Sertraline—Constipation—Carmustine—brain cancer	0.000139	0.000943	CcSEcCtD
Sertraline—Pain—Carmustine—brain cancer	0.000139	0.000943	CcSEcCtD
Sertraline—Malaise—Etoposide—brain cancer	0.000139	0.000942	CcSEcCtD
Sertraline—Vertigo—Etoposide—brain cancer	0.000138	0.000939	CcSEcCtD
Sertraline—Dyspepsia—Temozolomide—brain cancer	0.000138	0.000938	CcSEcCtD
Sertraline—Leukopenia—Etoposide—brain cancer	0.000138	0.000936	CcSEcCtD
Sertraline—Diarrhoea—Hydroxyurea—brain cancer	0.000137	0.000934	CcSEcCtD
Sertraline—Decreased appetite—Temozolomide—brain cancer	0.000136	0.000927	CcSEcCtD
Sertraline—Gastrointestinal disorder—Temozolomide—brain cancer	0.000135	0.00092	CcSEcCtD
Sertraline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000135	0.00614	CbGpPWpGaD
Sertraline—Fatigue—Temozolomide—brain cancer	0.000135	0.000919	CcSEcCtD
Sertraline—Loss of consciousness—Etoposide—brain cancer	0.000135	0.000919	CcSEcCtD
Sertraline—Cough—Etoposide—brain cancer	0.000134	0.000912	CcSEcCtD
Sertraline—Constipation—Temozolomide—brain cancer	0.000134	0.000912	CcSEcCtD
Sertraline—Pain—Temozolomide—brain cancer	0.000134	0.000912	CcSEcCtD
Sertraline—Feeling abnormal—Carmustine—brain cancer	0.000134	0.000909	CcSEcCtD
Sertraline—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000134	0.00606	CbGpPWpGaD
Sertraline—Convulsion—Etoposide—brain cancer	0.000133	0.000906	CcSEcCtD
Sertraline—Hypertension—Etoposide—brain cancer	0.000133	0.000902	CcSEcCtD
Sertraline—Dizziness—Hydroxyurea—brain cancer	0.000133	0.000902	CcSEcCtD
Sertraline—Gastrointestinal pain—Carmustine—brain cancer	0.000133	0.000902	CcSEcCtD
Sertraline—Chest pain—Etoposide—brain cancer	0.000131	0.00089	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.00013	0.000884	CcSEcCtD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00013	0.00588	CbGpPWpGaD
Sertraline—Discomfort—Etoposide—brain cancer	0.000129	0.000879	CcSEcCtD
Sertraline—Feeling abnormal—Temozolomide—brain cancer	0.000129	0.000878	CcSEcCtD
Sertraline—Abdominal pain—Carmustine—brain cancer	0.000128	0.000872	CcSEcCtD
Sertraline—Body temperature increased—Carmustine—brain cancer	0.000128	0.000872	CcSEcCtD
Sertraline—Gastrointestinal pain—Temozolomide—brain cancer	0.000128	0.000872	CcSEcCtD
Sertraline—Vomiting—Hydroxyurea—brain cancer	0.000128	0.000868	CcSEcCtD
Sertraline—ABCB1—central nervous system—brain cancer	0.000128	0.00276	CbGeAlD
Sertraline—Rash—Hydroxyurea—brain cancer	0.000127	0.00086	CcSEcCtD
Sertraline—Confusional state—Etoposide—brain cancer	0.000127	0.00086	CcSEcCtD
Sertraline—Dermatitis—Hydroxyurea—brain cancer	0.000127	0.00086	CcSEcCtD
Sertraline—Headache—Hydroxyurea—brain cancer	0.000126	0.000855	CcSEcCtD
Sertraline—Anaphylactic shock—Etoposide—brain cancer	0.000126	0.000853	CcSEcCtD
Sertraline—ABCB1—cerebellum—brain cancer	0.000125	0.00269	CbGeAlD
Sertraline—Urticaria—Temozolomide—brain cancer	0.000125	0.000847	CcSEcCtD
Sertraline—Abdominal pain—Temozolomide—brain cancer	0.000124	0.000843	CcSEcCtD
Sertraline—Body temperature increased—Temozolomide—brain cancer	0.000124	0.000843	CcSEcCtD
Sertraline—Thrombocytopenia—Etoposide—brain cancer	0.000123	0.000835	CcSEcCtD
Sertraline—Tachycardia—Etoposide—brain cancer	0.000123	0.000832	CcSEcCtD
Sertraline—Skin disorder—Etoposide—brain cancer	0.000122	0.000829	CcSEcCtD
Sertraline—Hyperhidrosis—Etoposide—brain cancer	0.000121	0.000825	CcSEcCtD
Sertraline—Anorexia—Etoposide—brain cancer	0.00012	0.000813	CcSEcCtD
Sertraline—Hypersensitivity—Carmustine—brain cancer	0.00012	0.000813	CcSEcCtD
Sertraline—Nausea—Hydroxyurea—brain cancer	0.000119	0.00081	CcSEcCtD
Sertraline—Hypotension—Etoposide—brain cancer	0.000117	0.000797	CcSEcCtD
Sertraline—Asthenia—Carmustine—brain cancer	0.000116	0.000791	CcSEcCtD
Sertraline—Hypersensitivity—Temozolomide—brain cancer	0.000116	0.000785	CcSEcCtD
Sertraline—Paraesthesia—Etoposide—brain cancer	0.000113	0.000766	CcSEcCtD
Sertraline—Asthenia—Temozolomide—brain cancer	0.000113	0.000765	CcSEcCtD
Sertraline—Dyspnoea—Etoposide—brain cancer	0.000112	0.00076	CcSEcCtD
Sertraline—Somnolence—Etoposide—brain cancer	0.000112	0.000758	CcSEcCtD
Sertraline—Diarrhoea—Carmustine—brain cancer	0.000111	0.000755	CcSEcCtD
Sertraline—Pruritus—Temozolomide—brain cancer	0.000111	0.000754	CcSEcCtD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00011	0.00498	CbGpPWpGaD
Sertraline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000109	0.00496	CbGpPWpGaD
Sertraline—Decreased appetite—Etoposide—brain cancer	0.000109	0.000741	CcSEcCtD
Sertraline—Gastrointestinal disorder—Etoposide—brain cancer	0.000108	0.000736	CcSEcCtD
Sertraline—Fatigue—Etoposide—brain cancer	0.000108	0.000735	CcSEcCtD
Sertraline—Dizziness—Carmustine—brain cancer	0.000107	0.000729	CcSEcCtD
Sertraline—Pain—Etoposide—brain cancer	0.000107	0.000729	CcSEcCtD
Sertraline—Constipation—Etoposide—brain cancer	0.000107	0.000729	CcSEcCtD
Sertraline—Diarrhoea—Temozolomide—brain cancer	0.000107	0.000729	CcSEcCtD
Sertraline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000104	0.00474	CbGpPWpGaD
Sertraline—Dizziness—Temozolomide—brain cancer	0.000104	0.000705	CcSEcCtD
Sertraline—Feeling abnormal—Etoposide—brain cancer	0.000103	0.000703	CcSEcCtD
Sertraline—Vomiting—Carmustine—brain cancer	0.000103	0.000701	CcSEcCtD
Sertraline—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000103	0.00468	CbGpPWpGaD
Sertraline—Gastrointestinal pain—Etoposide—brain cancer	0.000103	0.000697	CcSEcCtD
Sertraline—Rash—Carmustine—brain cancer	0.000102	0.000695	CcSEcCtD
Sertraline—Dermatitis—Carmustine—brain cancer	0.000102	0.000695	CcSEcCtD
Sertraline—Headache—Carmustine—brain cancer	0.000102	0.000691	CcSEcCtD
Sertraline—ABCB1—brain—brain cancer	0.000101	0.00219	CbGeAlD
Sertraline—Vomiting—Temozolomide—brain cancer	9.98e-05	0.000678	CcSEcCtD
Sertraline—Urticaria—Etoposide—brain cancer	9.97e-05	0.000678	CcSEcCtD
Sertraline—Abdominal pain—Etoposide—brain cancer	9.92e-05	0.000674	CcSEcCtD
Sertraline—Body temperature increased—Etoposide—brain cancer	9.92e-05	0.000674	CcSEcCtD
Sertraline—CYP2B6—Biological oxidations—CYP2C9—brain cancer	9.9e-05	0.00449	CbGpPWpGaD
Sertraline—Rash—Temozolomide—brain cancer	9.89e-05	0.000672	CcSEcCtD
Sertraline—Dermatitis—Temozolomide—brain cancer	9.88e-05	0.000671	CcSEcCtD
Sertraline—Headache—Temozolomide—brain cancer	9.83e-05	0.000668	CcSEcCtD
Sertraline—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	9.77e-05	0.00443	CbGpPWpGaD
Sertraline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	9.74e-05	0.00442	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—ESR2—brain cancer	9.64e-05	0.00437	CbGpPWpGaD
Sertraline—Nausea—Carmustine—brain cancer	9.64e-05	0.000655	CcSEcCtD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—STAT3—brain cancer	9.33e-05	0.00423	CbGpPWpGaD
Sertraline—Nausea—Temozolomide—brain cancer	9.32e-05	0.000633	CcSEcCtD
Sertraline—Hypersensitivity—Etoposide—brain cancer	9.25e-05	0.000628	CcSEcCtD
Sertraline—Asthenia—Etoposide—brain cancer	9.01e-05	0.000612	CcSEcCtD
Sertraline—Pruritus—Etoposide—brain cancer	8.88e-05	0.000603	CcSEcCtD
Sertraline—CYP3A4—Irinotecan Pathway—APC—brain cancer	8.87e-05	0.00402	CbGpPWpGaD
Sertraline—Diarrhoea—Etoposide—brain cancer	8.59e-05	0.000584	CcSEcCtD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	8.47e-05	0.00384	CbGpPWpGaD
Sertraline—Dizziness—Etoposide—brain cancer	8.3e-05	0.000564	CcSEcCtD
Sertraline—Vomiting—Etoposide—brain cancer	7.98e-05	0.000542	CcSEcCtD
Sertraline—Rash—Etoposide—brain cancer	7.92e-05	0.000538	CcSEcCtD
Sertraline—Dermatitis—Etoposide—brain cancer	7.91e-05	0.000537	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—ESR2—brain cancer	7.9e-05	0.00358	CbGpPWpGaD
Sertraline—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	7.87e-05	0.00357	CbGpPWpGaD
Sertraline—Headache—Etoposide—brain cancer	7.86e-05	0.000534	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—HES1—brain cancer	7.49e-05	0.0034	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP2C9—brain cancer	7.48e-05	0.00339	CbGpPWpGaD
Sertraline—Nausea—Etoposide—brain cancer	7.46e-05	0.000507	CcSEcCtD
Sertraline—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	7.38e-05	0.00335	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—S100A10—brain cancer	7.31e-05	0.00331	CbGpPWpGaD
Sertraline—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	7.23e-05	0.00328	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP2C9—brain cancer	6.88e-05	0.00312	CbGpPWpGaD
Sertraline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	6.82e-05	0.00309	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	6.79e-05	0.00308	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—S100A10—brain cancer	6.47e-05	0.00294	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—SIRT1—brain cancer	6.34e-05	0.00288	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—HES1—brain cancer	6.14e-05	0.00278	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	6.01e-05	0.00273	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP2C9—brain cancer	5.83e-05	0.00264	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	5.75e-05	0.00261	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—CDK4—brain cancer	4.8e-05	0.00217	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—PDGFRA—brain cancer	4.65e-05	0.00211	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.5e-05	0.00204	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.44e-05	0.00201	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP2C9—brain cancer	4.31e-05	0.00195	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	3.88e-05	0.00176	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.76e-05	0.0017	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	3.68e-05	0.00167	CbGpPWpGaD
Sertraline—MAOB—Metabolism—BSG—brain cancer	3.66e-05	0.00166	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.47e-05	0.00157	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—TRPC6—brain cancer	3.37e-05	0.00153	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.31e-05	0.0015	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	3.22e-05	0.00146	CbGpPWpGaD
Sertraline—MAOB—Metabolism—IDH1—brain cancer	3.15e-05	0.00143	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.12e-05	0.00142	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	3.11e-05	0.00141	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.08e-05	0.0014	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—TRPC6—brain cancer	2.99e-05	0.00136	CbGpPWpGaD
Sertraline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.91e-05	0.00132	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.87e-05	0.0013	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.71e-05	0.00123	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP2C9—brain cancer	2.7e-05	0.00123	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.66e-05	0.0012	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.55e-05	0.00116	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL2—brain cancer	2.54e-05	0.00115	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.5e-05	0.00113	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.49e-05	0.00113	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ENO2—brain cancer	2.49e-05	0.00113	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.47e-05	0.00112	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.44e-05	0.00111	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.39e-05	0.00108	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.39e-05	0.00108	CbGpPWpGaD
Sertraline—MAOA—Metabolism—BSG—brain cancer	2.3e-05	0.00104	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.3e-05	0.00104	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.24e-05	0.00102	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.19e-05	0.000992	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.16e-05	0.000979	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.1e-05	0.000953	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TP53—brain cancer	2.04e-05	0.000925	CbGpPWpGaD
Sertraline—MAOA—Metabolism—IDH1—brain cancer	1.98e-05	0.000896	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.92e-05	0.000869	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.89e-05	0.000858	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.78e-05	0.000808	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP2C9—brain cancer	1.69e-05	0.000768	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.64e-05	0.000742	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ENO2—brain cancer	1.56e-05	0.000709	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.49e-05	0.000674	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—BSG—brain cancer	1.44e-05	0.000653	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.38e-05	0.000627	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP2C9—brain cancer	1.28e-05	0.00058	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP2C9—brain cancer	1.25e-05	0.000566	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—IDH1—brain cancer	1.24e-05	0.000561	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.22e-05	0.000554	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.21e-05	0.000549	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP2C9—brain cancer	1.18e-05	0.000534	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CG—brain cancer	1.14e-05	0.000518	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—BSG—brain cancer	1.09e-05	0.000493	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.06e-05	0.000483	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—BSG—brain cancer	1.06e-05	0.000482	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—BSG—brain cancer	1e-05	0.000454	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP2C9—brain cancer	9.97e-06	0.000452	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—BSG—brain cancer	9.92e-06	0.00045	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	9.8e-06	0.000444	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ENO2—brain cancer	9.79e-06	0.000444	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	9.58e-06	0.000435	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—IDH1—brain cancer	9.36e-06	0.000424	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—IDH1—brain cancer	9.13e-06	0.000414	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—IDH1—brain cancer	8.61e-06	0.00039	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—IDH1—brain cancer	8.53e-06	0.000387	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—BSG—brain cancer	8.48e-06	0.000384	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	8.05e-06	0.000365	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP2C9—brain cancer	7.69e-06	0.000349	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.62e-06	0.000345	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ENO2—brain cancer	7.4e-06	0.000335	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—IDH1—brain cancer	7.29e-06	0.000331	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ENO2—brain cancer	7.22e-06	0.000327	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CG—brain cancer	7.17e-06	0.000325	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.95e-06	0.000315	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ENO2—brain cancer	6.8e-06	0.000308	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ENO2—brain cancer	6.74e-06	0.000306	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—BSG—brain cancer	6.54e-06	0.000297	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.94e-06	0.000269	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ENO2—brain cancer	5.76e-06	0.000261	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—IDH1—brain cancer	5.63e-06	0.000255	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CG—brain cancer	4.49e-06	0.000204	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ENO2—brain cancer	4.45e-06	0.000202	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CG—brain cancer	3.39e-06	0.000154	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CG—brain cancer	3.31e-06	0.00015	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CG—brain cancer	3.12e-06	0.000142	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CG—brain cancer	3.09e-06	0.00014	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CG—brain cancer	2.64e-06	0.00012	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CG—brain cancer	2.04e-06	9.25e-05	CbGpPWpGaD
